Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Precision Health Database


Precision Health Database|Search|PHGKB

Last data update: Sep 22, 2023. (Total: 61629 Documents since 2012)
   dataset      
Filtered By:

Previous    

Records 1 - 30 (of 105 Records)

Next

Query Trace:
The spectrum of MAPK-ERK pathway genomic alterations in gynecologic malignancies: Opportunities for novel therapeutic approaches.
Dimitrios Nasioudis et al. Gynecol Oncol 2023 17786-94
A Novel HPV/Host DNA Methylation-Score and Detection of Cervical Adenocarcinoma.
Ana Gradissimo et al. J Natl Cancer Inst 2023
An Overview of the Use of Precision Population Medicine in Cancer Care: First of a Series.
Johnny Yang et al. Cureus 2023 15(4) e37889
p16 flow cytometry of exfoliated cervical cells: Its role in quantitative pathology and clinical diagnosis of squamous intraepithelial lesions.
Yifeng He et al. Clinical and translational medicine 2023 13(3) e1209
Cervical Cancer Stage at Diagnosis and Survival among Women ≥65 Years in California.
Cooley Julianne J P et al. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2023 32(1) 91-97
DNA methylation-based detection and prediction of cervical intraepithelial neoplasia grade 3 and invasive cervical cancer with the WID™-qCIN test.
Herzog Chiara et al. Clinical epigenetics 2022 14(1) 150
The WID-CIN test identifies women with, and at risk of, cervical intraepithelial neoplasia grade 3 and invasive cervical cancer
JE Barrett et al, Genome Medicine, October 19, 2022
Enrollment of Individuals From Racial and Ethnic Minority Groups in Gynecologic Cancer Precision Oncology Trials.
Mattei Larissa H et al. Obstetrics and gynecology 2022
Extended human papillomavirus genotyping to predict progression to high-grade cervical precancer: A prospective cohort study in the southeastern United States.
Bukowski Alexandra et al. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2022
HPV E1 qPCR, a Low-Cost Alternative Assay to Roche Diagnostic Linear Array is Effective in Identifying Women at Risk for Developing Cervical Cancer.
Piyathilake Chandrika J et al. International journal of women's health 2022 14257-266
Does Direct-to-Consumer Personal Genetic Testing Improve Gynecological Cancer Screening Uptake among Never-Screened Attendees? A Randomized Controlled Study.
Watanabe Miki et al. International journal of environmental research and public health 2021 18(23)
Patient-Reported Factors Associated With Older Adults' Cancer Screening Decision-making: A Systematic Review.
Smith Jenna et al. JAMA network open 2021 4(11) e2133406
Clinical Outcomes of Genotype-Matched Therapy for Recurrent Gynecological Cancers: A Single Institutional Experience.
Sawada Kiyoka et al. Healthcare (Basel, Switzerland) 2021 9(10)
Bioinformatic identification of genomic instability-associated lncRNAs signatures for improving the clinical outcome of cervical cancer by a prognostic model.
Zhang Jian et al. Scientific reports 2021 11(1) 20929
NGS-guided precision oncology in metastatic breast and gynecological cancer: first experiences at the CCC Munich LMU.
Sultova Elena et al. Archives of gynecology and obstetrics 2020 Dec
Six-lncRNA Immune Prognostic Signature for Cervical Cancer.
Chen Qian et al. Frontiers in genetics 2020 11533628
Evaluation of the SureX HPV genotyping test for the detection of high-risk HPV in cervical cancer screening.
Wei Baojun et al. Virology journal 2020 Nov 17(1) 171
Fine Mapping of the Major Histocompatibility Complex Region and Association of the HLA-B*52:01 Allele With Cervical Cancer in Japanese Women.
Masuda Tatsuo et al. JAMA network open 2020 Oct 3(10) e2023248
Assessing 10-year safety of a single negative HPV test for cervical cancer screening: Evidence from FOCAL-DECADE cohort.
Gottschlich Anna et al. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2020 Oct
Designing low-cost, accurate cervical screening strategies that take into account COVID-19: a role for self-sampled HPV typing2.
Ajenifuja Kayode Olusegun et al. Infectious agents and cancer 2020 1561
Genetic markers and phosphoprotein forms of beta-catenin pβ-Cat552 and pβ-Cat675 are prognostic biomarkers of cervical cancer
SM Scholl et al, EBiomedicine, October 21, 2020
Methylation markers FAM19A4 and miR124-2 as triage strategy for primary HPV screen positive women; A large European multi-center study.
Bonde Jesper et al. International journal of cancer 2020 Sep
Differences in Breast and Cervical Cancer Screening Among U.S. Women by Nativity and Family History.
Donley Tiffany et al. American journal of preventive medicine 2020 Aug
Prognostic Value and Potential Role of Alternative mRNA Splicing Events in Cervical Cancer.
Shao Xiang-Yang et al. Frontiers in genetics 2020 11726
A prognostic nomogram integrating novel biomarkers identified by machine learning for cervical squamous cell carcinoma.
Li Yimin et al. Journal of translational medicine 2020 Jun 18(1) 223
Clinical Applications of Telemedicine in Gynecology and Women's Health.
Lee Siwon et al. Obstetrics and gynecology clinics of North America 2020 Jun 47(2) 259-270
Identification of miRNA-mRNA Regulatory Network and Construction of Prognostic Signature in Cervical Cancer.
Mei Yong et al. DNA and cell biology 2020 Apr
A Five-Genes-Based Prognostic Signature for Cervical Cancer Overall Survival Prediction.
Zhao Menghuang et al. International journal of genomics 2020 20208347639
A 10-gene prognostic methylation signature for stage I-III cervical cancer.
Cai Shengyun et al. Archives of gynecology and obstetrics 2020 Apr
An 8‑gene signature predicts the prognosis of cervical cancer following radiotherapy.
Xie Fei et al. Molecular medicine reports 2019 Oct 20(4) 2990-3002
TOP